Navigation Links
Microbix' Pipeline Set To Reach Milestones In 2010
Date:12/16/2009

just been approved for sale in Canada and already garnered a guaranteed purchase of 50,000 vials; and SST(TM), (Semen Sexing Technology), a process that will allow livestock producers to pre-select the sex of offspring before conception, is the focus of licensing discussions with several global animal health companies," Gastle added.

    Microbix 2009 achievements:

    VIRUSMAX
    --------

In October, the company announced a financing agreement with Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) to begin construction on Asia's largest vaccine facility using Microbix VIRUSMAX technology. Microbix will begin earning revenue from management fees by 2012 and expects to realize vaccine sales from this facility for the 2014 flu season. The company will receive fees and future royalties of more than $25 million per year when the plant reaches full capacity and will initially participate with a 50% equity interest. In addition, Microbix and Hunan Biopharmaceutical have signed an initial vaccine supply agreement covering seven years with a value of approximately $500 million (USD.)

Financing for this large project has been delayed in part because of the global capital markets environment since the summer of 2008. Hunan Biopharmaceutical is financing the initial construction beginning in the first quarter of 2010. During Phase 1 of the project, both partners will raise money; however, the increased funding will be non-dilutive for Microbix because the company will raise proceeds through its Barbados subsidiary, established for this purpose.

The facility will be constructed and financed in three stages. Phase 1 will provide 20 million doses by 2014 leading up to Phase 3 capacity in 2017 to produce more than 120 million doses of seasonal influenza vaccine annually, and over 300 million doses of a pandemic influenza vaccine in the event of an outbreak to immunize against a single strain of influenza.'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
4. Microbix Announces A New Technology Platform For The SST Project
5. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
6. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
7. Microbix Sales Grow 22% For Nine Months
8. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
9. Microbix Biosystems Provides a Corporate Update
10. Microbix Biosystems Re-files Annual Results With OSC
11. Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... 24, 2014 -- A novel combination of microscopy and ... Energy,s Oak Ridge National Laboratory an unprecedented look at ... physical and electrochemical properties. , The research team ... the surface of a perovskite manganite, a complex material ... avenue to understand surface behavior could benefit researchers who ...
(Date:7/24/2014)... equipment, trained personnel, and detection dogs to safeguard ... A revolutionary new electronic chip with nano-sized chemical ... easier. , The groundbreaking nanotechnology-inspired sensor, devised by ... School of Chemistry and Center for Nanoscience and ... picks up the scent of explosives molecules better ...
(Date:7/24/2014)... DUBLIN , July 24, 2014 ... the "Global Cell Culture Market 2014-2018" report ... Cell culture is the in vitro ... such as research, cell studies, and biopharmaceutical production. Cell ... vaccine production. Cell culture instruments and cell culture consumables ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6ORNL study reveals new characteristics of complex oxide surfaces 2Nano-sized chip 'sniffs out' explosives far better than trained dogs 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2
... , , , ... company Viral Genetics (Pink Sheets: VRAL) has formed a wholly ... advance a technology developed by University of Colorado Professor M. ... blocking a tumor cell,s ability to generate energy from glucose ...
... SALEM, N.H., Aug. 7 ALPCO Diagnostics has introduced a ... I SA kit that facilitates the testing process ... other methods for determining mouse HMW adiponectin and was first introduced in ... Tsukuba Research Institute in the journal Clinica Chimica Acta in February 2009. ...
... , RANCHO CORDOVA, Calif., Aug. 6 ... supplier of innovative products for processing and storing adult stem cells, ... of SpineSmith, LLC, related to the Company,s bone marrow products, MXP(TM) ... leading distributor of orthopedic products, based in Texas. , ...
Cached Biology Technology:Viral Genetics Creates Subsidiary to Develop Cancer Therapy 2Viral Genetics Creates Subsidiary to Develop Cancer Therapy 3Viral Genetics Creates Subsidiary to Develop Cancer Therapy 4ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 2ThermoGenesis Announces Expanded Collaboration With Celling Technologies 2ThermoGenesis Announces Expanded Collaboration With Celling Technologies 3ThermoGenesis Announces Expanded Collaboration With Celling Technologies 4
(Date:7/27/2014)... from over 18,000 patients, scientists have identified more ... Parkinson,s disease, including six that had not been ... Genetics , was partially funded by the National ... working in NIH laboratories. , "Unraveling the genetic ... multiple mechanisms involved in this complex disease, and ...
(Date:7/25/2014)... WASHINGTON (July 24, 2014)The link between autism and ... the puzzle of the disease, and is largely ... Foundation Autism Research Initiative (SFARI), George Washington University ... to offer truly integrative and in-depth answers to ... research. , LaMantia, professor of pharmacology and ...
(Date:7/25/2014)... opened the way for the development of new lines of ... barley production is second only to wheat with 7-8 million ... important diseases of barley. , Senior Research Scientist Dr Alan ... on the cell walls of barley plants that block the ... by the ARC Centre of Excellence in Plant Cell Walls ...
Breaking Biology News(10 mins):NIH scientists find 6 new genetic risk factors for Parkinson's 2GW researcher receives grant to answer the how and why of autism during development 2New hope for powdery mildew resistant barley 2
... a way, nanotubes are nature’s smallest candles. , These tiny ... small that it takes about 100,000 laid side-by-side to span ... five years, scientists have discovered that some individual nanotubes are ... light. Some glow brightly. Others glow dimly. Some glow in ...
... specialists associated with the Neuroscience Institute at the ... the ability to incorporate—in real time—two high-tech imaging ... functional abilities of patients who undergo brain surgery. ... UC colleagues are among the first in the ...
... team has discovered a gene that, when mutated, causes one ... Scientists at the University of Leeds, working in collaboration with ... which is essential to photoreceptors in the eye, the cells ... to be linked to Leber’s congenital amaurosis (LCA), comes at ...
Cached Biology News:Brightening prospects of using fluorescent nanotubes in medical applications 2Brightening prospects of using fluorescent nanotubes in medical applications 3Dual-imaging technique useful before -- and during -- brain surgery 2'Lucky 13' as new gene discovery offers further hope for childhood blindness 2'Lucky 13' as new gene discovery offers further hope for childhood blindness 3